The 12 closest competitors and alternatives to Smart Health Diagnostics Co among healthcare diagnostics companies — ranked by similarity to what Smart Health Diagnostics Co actually does, not by market-cap band.
Subscribe to see Smart Health Diagnostics Co’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Smart Health Diagnostics Co. operates as a healthcare diagnostics holding company that oversees specialized portfolio businesses focused on pathology, oncology, and vascular diagnostics. The company provides slide-free digital pathology technology through its MUSE microscopy system and offers vascular diagnostic tools like SmartVascular Dx to detect vascular inflammation for clinicians and healthcare systems.
Smart Health Diagnostics Co is a healthcare diagnostics company headquartered in United States. Its most recent funding round raised $300,000 in November 2024. Xcout tracks 12 named people at Smart Health Diagnostics Co, including Larry Dentice (CEO & Director).
6 more named people on record for Smart Health Diagnostics Co, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $300,000 | — | |
| SEC Form D filing | $1.3M | — | |
| Pre-Seed | $15.6M | — | |
| SEC Form D filing | $15.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Smart Health Diagnostics Co by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology & Medical Diagnostics
Biocare Medical develops and supplies advanced staining instruments, primary antibodies, and detection reagents for immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The company serves clinical laboratories, research facilities, and pathologists by providing integrated automated staining platforms and testing solutions.
Biotechnology
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Biotechnology
TopoDx, Inc. develops physical AI technology for clinical microbiology to provide rapid microbial topographies for pathogen identification and antimicrobial susceptibility testing. The company serves hospitals and healthcare providers by delivering faster sample triage to enable quicker and more effective infection treatments.
Biotech
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.
Medical Diagnostics and IT
Zafena AB develops, manufactures, and distributes medical diagnostic equipment and digital workflow automation solutions for point-of-care testing.
Medical Diagnostics
Sysmex Deutschland GmbH develops and distributes laboratory analysis systems and diagnostic solutions, specializing in fields such as hematology, urinalysis, and life sciences.
Medical Technology
Ventana Medical Systems, Inc. is a U.S.-based medical technology company that develops automated tissue-diagnostics instruments, reagents, and software for pathology and oncology testing. It serves hospital and clinical laboratories, pathologists, and biomedical researchers, and has been part of Roche since its acquisition in 2008.
Medical Technology
Forward Science Holding Inc. is a medical technology company that develops and manufactures oral health products and screening devices, including oral cancer screening tools and periodontal treatments. The company serves dental professionals and clinical practices to improve patient oral care outcomes.
Healthcare
Sensydia Corp is a medical devices and equipment company established in 2015 and based in Los Angeles, California. The company develops diagnostic technologies and non-invasive cardiac monitoring systems.
Healthcare
Caristo Diagnostics is a medical equipment manufacturing company headquartered in Oxford, United Kingdom. It specializes in developing medical devices for the diagnosis of vascular disease, operating with international presence including an office in Stamford, USA.
Healthcare
Digital Diagnostics Inc. develops automated AI diagnostic systems, such as LumineticsCore and IDx-DR, designed to transform global healthcare.
Health Care
QLife Holding develops medical technology products, specifically featuring the Egoo platform for decentralized biomarker and blood testing. The company provides accessible diagnostic equipment designed for patients to use at home.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Smart Health Diagnostics Coand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →